83 related articles for article (PubMed ID: 15109648)
1. Structure-activity requirements for the antiproliferative effect of troglitazone derivatives mediated by depletion of intracellular calcium.
Fan YH; Chen H; Natarajan A; Guo Y; Harbinski F; Iyasere J; Christ W; Aktas H; Halperin JA
Bioorg Med Chem Lett; 2004 May; 14(10):2547-50. PubMed ID: 15109648
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation.
Chen H; Fan YH; Natarajan A; Guo Y; Iyasere J; Harbinski F; Luus L; Christ W; Aktas H; Halperin JA
Bioorg Med Chem Lett; 2004 Nov; 14(21):5401-5. PubMed ID: 15454234
[TBL] [Abstract][Full Text] [Related]
3. 3,3-diaryl-1,3-dihydroindol-2-ones as antiproliferatives mediated by translation initiation inhibition.
Natarajan A; Fan YH; Chen H; Guo Y; Iyasere J; Harbinski F; Christ WJ; Aktas H; Halperin JA
J Med Chem; 2004 Apr; 47(8):1882-5. PubMed ID: 15055987
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new troglitazone derivatives: anti-proliferative activity in breast cancer cell lines and preliminary toxicological study.
Salamone S; Colin C; Grillier-Vuissoz I; Kuntz S; Mazerbourg S; Flament S; Martin H; Richert L; Chapleur Y; Boisbrun M
Eur J Med Chem; 2012 May; 51():206-15. PubMed ID: 22409968
[TBL] [Abstract][Full Text] [Related]
5. Development of small-molecule cyclin D1-ablative agents.
Huang JW; Shiau CW; Yang J; Wang DS; Chiu HC; Chen CY; Chen CS
J Med Chem; 2006 Jul; 49(15):4684-9. PubMed ID: 16854074
[TBL] [Abstract][Full Text] [Related]
6. Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity.
He G; Sung YM; Digiovanni J; Fischer SM
Cancer Res; 2006 Feb; 66(3):1873-8. PubMed ID: 16452250
[TBL] [Abstract][Full Text] [Related]
7. Novel arylsulfoanilide-oxindole hybrid as an anticancer agent that inhibits translation initiation.
Natarajan A; Guo Y; Harbinski F; Fan YH; Chen H; Luus L; Diercks J; Aktas H; Chorev M; Halperin JA
J Med Chem; 2004 Oct; 47(21):4979-82. PubMed ID: 15456240
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis.
Little PJ; Ballinger ML; Survase S; Osman N; Ogru E; Geytenbeek S; Bruemmer D; Nigro J
J Cardiovasc Pharmacol; 2008 Mar; 51(3):274-9. PubMed ID: 18356692
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells.
Yu HN; Noh EM; Lee YR; Roh SG; Song EK; Han MK; Lee YC; Shim IK; Lee SJ; Jung SH; Kim JS; Youn HJ
Biochem Biophys Res Commun; 2008 Dec; 377(1):242-7. PubMed ID: 18835379
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone inhibits endothelial cell proliferation through suppression of casein kinase 2 activity.
Lee KS; Park JH; Lee S; Lim HJ; Jang Y; Park HY
Biochem Biophys Res Commun; 2006 Jul; 346(1):83-8. PubMed ID: 16759638
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer activity of a novel class of flavonoids: 2,4-diarylchromane[4,3-d]-delta(1,9b)-1,2,3-thiadiazolines.
Ying H; Hu Y; He Q; Li R; Yang B
Eur J Med Chem; 2007 Feb; 42(2):226-34. PubMed ID: 17137679
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
Yang CC; Wang YC; Wei S; Lin LF; Chen CS; Lee CC; Lin CC; Chen CS
Cancer Res; 2007 Apr; 67(7):3229-38. PubMed ID: 17409431
[TBL] [Abstract][Full Text] [Related]
13. Small-Molecule targeting of translation initiation for cancer therapy.
Aktas BH; Qiao Y; Ozdelen E; Schubert R; Sevinc S; Harbinski F; Grubissich L; Singer S; Halperin JA
Oncotarget; 2013 Oct; 4(10):1606-17. PubMed ID: 24091475
[TBL] [Abstract][Full Text] [Related]
14. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells.
Motomura W; Nagamine M; Tanno S; Sawamukai M; Takahashi N; Kohgo Y; Okumura T
J Gastroenterol; 2004; 39(5):461-8. PubMed ID: 15175945
[TBL] [Abstract][Full Text] [Related]
16. Depletion of intracellular Ca2+ stores, phosphorylation of eIF2alpha, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole.
Aktas H; Flückiger R; Acosta JA; Savage JM; Palakurthi SS; Halperin JA
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8280-5. PubMed ID: 9653178
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
[TBL] [Abstract][Full Text] [Related]
18. Optimization of troglitazone derivatives as potent anti-proliferative agents: towards more active and less toxic compounds.
Bordessa A; Colin-Cassin C; Grillier-Vuissoz I; Kuntz S; Mazerbourg S; Husson G; Vo M; Flament S; Martin H; Chapleur Y; Boisbrun M
Eur J Med Chem; 2014 Aug; 83():129-40. PubMed ID: 24953030
[TBL] [Abstract][Full Text] [Related]
19. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
Komatsu Y; Ito I; Wayama M; Fujimura A; Akaogi K; Machida H; Nakajima Y; Kuroda T; Ohmori K; Murayama A; Kimura K; Yanagisawa J
Biochem Biophys Res Commun; 2008 May; 370(1):145-8. PubMed ID: 18355447
[TBL] [Abstract][Full Text] [Related]
20. Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture.
Skurk T; Birgel M; Lee YM; Hauner H
Metabolism; 2006 Mar; 55(3):309-16. PubMed ID: 16483873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
